Evolent Health Inc. (NYSE:EVH) rose 2.8% during trading on Friday . The stock traded as high as $23.65 and last traded at $23.65, with a volume of 62,927 shares changing hands. The stock had previously closed at $23.00.

EVH has been the topic of several recent research reports. FBR & Co initiated coverage on shares of Evolent Health in a report on Tuesday, March 29th. They set an “outperform” rating and a $16.00 price objective on the stock. Leerink Swann reaffirmed an “outperform” rating and set a $20.00 price objective on shares of Evolent Health in a report on Sunday, July 17th. Canaccord Genuity reaffirmed a “buy” rating on shares of Evolent Health in a report on Thursday, May 26th. Finally, Zacks Investment Research raised shares of Evolent Health from a “sell” rating to a “hold” rating in a report on Wednesday, May 18th. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. The company has an average rating of “Buy” and an average price target of $21.00.

The stock has a market cap of $1.44 billion and a PE ratio of 6.40. The stock has a 50 day moving average price of $18.47 and a 200 day moving average price of $12.96.

Evolent Health (NYSE:EVH) last posted its quarterly earnings results on Thursday, May 12th. The company reported ($0.16) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.19) by $0.03. The company earned $49.50 million during the quarter, compared to analysts’ expectations of $47.40 million. The firm’s revenue was up 33.8% on a year-over-year basis. On average, analysts predict that Evolent Health Inc. will post ($0.62) EPS for the current year.

A hedge fund recently raised its stake in Evolent Health stock. Schroder Investment Management Group increased its stake in Evolent Health Inc. (NYSE:EVH) by 120.1% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 355,922 shares of the company’s stock after buying an additional 194,222 shares during the period. Schroder Investment Management Group owned about 0.60% of Evolent Health worth $4,310,000 as of its most recent filing with the SEC.

Evolent Health, Inc supports integrated health systems in their migration towards value-based care and population health management. The Company’s services include providing customers with a population management platform, integrated data and analytics capabilities, pharmacy benefit management services and health plan administration services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.